A interesting study published in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology (Edson Luiz Cetira-Filho and et. al. Preemptive vs. Preventive Coadministration of Ibuprofen L-Arginine and Dexamethasone in Lower Third Molar Surgeries: A Randomized Controlled Trial, 2024) suggests that a combination of ibuprofen-arginine (Ib-Ar) and dexamethasone (DX) could be a more effective pain management strategy for patients undergoing lower wisdom teeth surgery.
Researchers from the Federal University of Ceará in Brazil conducted a randomized controlled trial involving 48 adult patients who were having lower widomt teeth extracted. Participants were divided into four groups, each receiving a different combination of Ib-Ar and DX or a placebo. The study evaluated various outcomes, including pain intensity, trismus (jaw stiffness), quality of life, pain catastrophizing, and sleep quality. Pain intensity was measured using a 10-cm visual analog scale and quality of life was determined from the Oral Health Impact Profile (OHIP-14). Trismus was calculated by measuring the maximum mouth-opening. Pain was assessed using a 13-item scale, and sleep quality was measured using the Pittsburgh Sleep Quality Index (PSQI).
The results were promising. Patients who received the combination of Ib-Ar and DX experienced lower overall pain scores and required less postoperative pain medication compared to those who received placebos. All groups saw a significant drop in pain from seven days onward, with no significant differences but the combination of Ib-Ar + DX group had the lowest overall pain scores. Initial mouth opening was found to be the same across groups. The P-Ib-Ar + P-DX group had the smallest cumulative mouth opening (p = 0.022). For quality of life scores no significant differences were observed between the groups.
Photo by Markus Spiske on Unsplash
While the study did not find significant differences in quality of life or pain catastrophizing between the groups, it’s important to note that those who received placebos had the worst outcomes. This suggests that the combination of Ib-Ar and DX may be particularly beneficial for patients who are at risk for severe pain or other complications.
However, the study did have some limitations. The researchers only evaluated one specific combination of Ib-Ar and DX, and did not compare it to other nonsteroidal anti-inflammatory drugs (NSAIDs). Additional future research is needed to determine of this combination compares to other pain management options.
Overall, the findings of this study suggest that a combination of ibuprofen-arginine (770 mg) and dexamethasone (8 mg) could be a promising approach for managing pain after lower wisdom teeth surgery.